Cannabis formulation reduces morphine use by nearly half in clinical trial
Patients given a single, high dose of a cannabis-based medicine used 48% less morphine over 24 hours than those given a placebo in a randomised clinical trial. This story first appeared on leafie, view here Author: Kevin Dinneen